FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995092114> ?p ?o ?g. }

• W1995092114 endingPage "247" @default.
• W1995092114 startingPage "241" @default.
• W1995092114 abstract "BackgroundWe assessed the survival rates regarding different stages of operable lung cancers causing operable brain metastasis in patients with or without cancer-related symptoms. The correlation between survival rates and the disease-free interval between lung surgery and metastasectomy was studied.MethodsSixty-five patients were operated on for lung cancer and brain metastases. The disease-free interval was divided into 5 subgroups: 0–2 months, 3–5 months, 6–11 months, 12–23 months, and 24 months and beyond. The study group comprised of patients with lung cancer in the following stages: 17 patients in stage I (1 patient in stage IA, 16 patients in stage IB), 16 patients in stage II (2 patients in stage IIA, 14 patients in stage IIB), 9 patients in stage IIIA, 4 patients in stage IIIB, and 19 patients in stage IV. Forty-four patients were symptom-free for lung cancer and 21 patients manifested lung cancer related symptoms.ResultsThe 5-year survival rates were as follows: stage I = 22%, stage II = 20%, stage IIIA = 22%, stage IIIB = 0%, and stage IV = 23% after lung resections. There were no significant differences in the 5-year survival rates regarding the disease-free interval subgroups after brain metastasectomies (p = 0.19): disease-free interval 0–2 months = 22% and disease-free interval 24 months and beyond = 23%. The 5-year survival rate after metastasectomy was significantly greater (26% vs 5%) in patients without lung cancer related symptoms (p = 0.05).ConclusionsThe 5-year survival rate in stage I, II, IIIA, and IV lung cancer with operable hematogenous brain metastases corresponds to that in the customary stage IIIA (23%). The disease-free interval exhibited no significant impact on the survival rate. The complaint-free status exhibits a significantly greater impact on the survival rate in hematogenic metastasis. We assessed the survival rates regarding different stages of operable lung cancers causing operable brain metastasis in patients with or without cancer-related symptoms. The correlation between survival rates and the disease-free interval between lung surgery and metastasectomy was studied. Sixty-five patients were operated on for lung cancer and brain metastases. The disease-free interval was divided into 5 subgroups: 0–2 months, 3–5 months, 6–11 months, 12–23 months, and 24 months and beyond. The study group comprised of patients with lung cancer in the following stages: 17 patients in stage I (1 patient in stage IA, 16 patients in stage IB), 16 patients in stage II (2 patients in stage IIA, 14 patients in stage IIB), 9 patients in stage IIIA, 4 patients in stage IIIB, and 19 patients in stage IV. Forty-four patients were symptom-free for lung cancer and 21 patients manifested lung cancer related symptoms. The 5-year survival rates were as follows: stage I = 22%, stage II = 20%, stage IIIA = 22%, stage IIIB = 0%, and stage IV = 23% after lung resections. There were no significant differences in the 5-year survival rates regarding the disease-free interval subgroups after brain metastasectomies (p = 0.19): disease-free interval 0–2 months = 22% and disease-free interval 24 months and beyond = 23%. The 5-year survival rate after metastasectomy was significantly greater (26% vs 5%) in patients without lung cancer related symptoms (p = 0.05). The 5-year survival rate in stage I, II, IIIA, and IV lung cancer with operable hematogenous brain metastases corresponds to that in the customary stage IIIA (23%). The disease-free interval exhibited no significant impact on the survival rate. The complaint-free status exhibits a significantly greater impact on the survival rate in hematogenic metastasis." @default.
• W1995092114 created "2016-06-24" @default.
• W1995092114 creator A5016632566 @default.
• W1995092114 creator A5017416269 @default.
• W1995092114 creator A5020468330 @default.
• W1995092114 creator A5043431868 @default.
• W1995092114 creator A5043962045 @default.
• W1995092114 creator A5044702412 @default.
• W1995092114 creator A5057257315 @default.
• W1995092114 creator A5076929032 @default.
• W1995092114 creator A5085060640 @default.
• W1995092114 date "2005-01-01" @default.
• W1995092114 modified "2023-10-18" @default.
• W1995092114 title "Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems" @default.
• W1995092114 cites W1969948448 @default.
• W1995092114 cites W1972209863 @default.
• W1995092114 cites W1982372171 @default.
• W1995092114 cites W1990936385 @default.
• W1995092114 cites W1991340699 @default.
• W1995092114 cites W1993312546 @default.
• W1995092114 cites W2030505692 @default.
• W1995092114 cites W2039202448 @default.
• W1995092114 cites W2068214103 @default.
• W1995092114 cites W2086794546 @default.
• W1995092114 cites W2157216324 @default.
• W1995092114 cites W2163629116 @default.
• W1995092114 cites W2166812357 @default.
• W1995092114 cites W4247464893 @default.
• W1995092114 cites W4293363005 @default.
• W1995092114 cites W4323873968 @default.
• W1995092114 doi "https://doi.org/10.1016/j.athoracsur.2004.06.051" @default.
• W1995092114 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15620950" @default.
• W1995092114 hasPublicationYear "2005" @default.
• W1995092114 type Work @default.
• W1995092114 sameAs 1995092114 @default.
• W1995092114 citedByCount "57" @default.
• W1995092114 countsByYear W19950921142012 @default.
• W1995092114 countsByYear W19950921142013 @default.
• W1995092114 countsByYear W19950921142014 @default.
• W1995092114 countsByYear W19950921142015 @default.
• W1995092114 countsByYear W19950921142016 @default.
• W1995092114 countsByYear W19950921142017 @default.
• W1995092114 countsByYear W19950921142018 @default.
• W1995092114 countsByYear W19950921142019 @default.
• W1995092114 countsByYear W19950921142020 @default.
• W1995092114 countsByYear W19950921142021 @default.
• W1995092114 countsByYear W19950921142022 @default.
• W1995092114 countsByYear W19950921142023 @default.
• W1995092114 crossrefType "journal-article" @default.
• W1995092114 hasAuthorship W1995092114A5016632566 @default.
• W1995092114 hasAuthorship W1995092114A5017416269 @default.
• W1995092114 hasAuthorship W1995092114A5020468330 @default.
• W1995092114 hasAuthorship W1995092114A5043431868 @default.
• W1995092114 hasAuthorship W1995092114A5043962045 @default.
• W1995092114 hasAuthorship W1995092114A5044702412 @default.
• W1995092114 hasAuthorship W1995092114A5057257315 @default.
• W1995092114 hasAuthorship W1995092114A5076929032 @default.
• W1995092114 hasAuthorship W1995092114A5085060640 @default.
• W1995092114 hasConcept C121608353 @default.
• W1995092114 hasConcept C126322002 @default.
• W1995092114 hasConcept C141071460 @default.
• W1995092114 hasConcept C143998085 @default.
• W1995092114 hasConcept C146357865 @default.
• W1995092114 hasConcept C151730666 @default.
• W1995092114 hasConcept C2776256026 @default.
• W1995092114 hasConcept C2776283816 @default.
• W1995092114 hasConcept C2777714996 @default.
• W1995092114 hasConcept C2778164965 @default.
• W1995092114 hasConcept C2778601017 @default.
• W1995092114 hasConcept C2779013556 @default.
• W1995092114 hasConcept C71924100 @default.
• W1995092114 hasConcept C86803240 @default.
• W1995092114 hasConceptScore W1995092114C121608353 @default.
• W1995092114 hasConceptScore W1995092114C126322002 @default.
• W1995092114 hasConceptScore W1995092114C141071460 @default.
• W1995092114 hasConceptScore W1995092114C143998085 @default.
• W1995092114 hasConceptScore W1995092114C146357865 @default.
• W1995092114 hasConceptScore W1995092114C151730666 @default.
• W1995092114 hasConceptScore W1995092114C2776256026 @default.
• W1995092114 hasConceptScore W1995092114C2776283816 @default.
• W1995092114 hasConceptScore W1995092114C2777714996 @default.
• W1995092114 hasConceptScore W1995092114C2778164965 @default.
• W1995092114 hasConceptScore W1995092114C2778601017 @default.
• W1995092114 hasConceptScore W1995092114C2779013556 @default.
• W1995092114 hasConceptScore W1995092114C71924100 @default.
• W1995092114 hasConceptScore W1995092114C86803240 @default.
• W1995092114 hasIssue "1" @default.
• W1995092114 hasLocation W19950921141 @default.
• W1995092114 hasLocation W19950921142 @default.
• W1995092114 hasOpenAccess W1995092114 @default.
• W1995092114 hasPrimaryLocation W19950921141 @default.
• W1995092114 hasRelatedWork W1901160194 @default.
• W1995092114 hasRelatedWork W1995092114 @default.
• W1995092114 hasRelatedWork W2017971528 @default.
• W1995092114 hasRelatedWork W2347402903 @default.
• W1995092114 hasRelatedWork W2353012075 @default.
• W1995092114 hasRelatedWork W2364112458 @default.
• W1995092114 hasRelatedWork W2516942920 @default.

• next